Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis

Mutations in the mismatch repair (MMR) system predict the response to immune checkpoint inhibitors (ICIs) like colon or gastric cancer. However, the MMR system’s involvement in non-small cell lung cancer (NSCLC) remains unknown. Addressing this issue will improve clinical guidelines in the case of m...

Full description

Bibliographic Details
Published in:	Biomedicines
Main Authors:	Alejandro Olivares-Hernández, Edel del Barco Morillo, Carmen Parra Pérez, José Pablo Miramontes-González, Luis Figuero-Pérez, Teresa Martín-Gómez, Roberto Escala-Cornejo, Lorena Bellido Hernández, Rogelio González Sarmiento, Juan Jesús Cruz-Hernández, María Dolores Ludeña de la Cruz
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Subjects:	MMR system immunotherapy ICIs NSCLC dMMR/MSI-H survival
Online Access:	https://www.mdpi.com/2227-9059/10/2/360

Similar Items

DNA Mismatch Repair Proteins and BRAF V600E Detection by Immunohistochemistry in Colorectal Cancer Demonstrates Concordance with Next Generation Sequencing
by: Joel Yambert, et al.
Published: (2022-12-01)

A Narrative Approach to Mismatch Repair-Deficient Endometrial Cancer
by: Massimo Barberis, et al.
Published: (2026-04-01)

An Insight into Deficient Mismatch Repair Colorectal Cancer Screening in a Romanian Population—A Bi-Institutional Pilot Study
by: Cristina Lungulescu, et al.
Published: (2021-08-01)

Concordance in detection of microsatellite instability by PCR and NGS in routinely processed tumor specimens of several cancer types
by: Stephan Bartels, et al.
Published: (2023-08-01)

Impact of germline MMR gene variants on immune checkpoint inhibitors response in patients with MSI-H/dMMR digestive cancers: a retrospective cohort analysis
by: Antoine Dardenne, et al.
Published: (2026-04-01)

Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment for mismatch-repair-deficient (dMMR) or microsatellite-instability-high (MSI-H) advanced or metastatic colorectal cancer from the perspective of the Chinese health-care system
by: Chen Zhu, et al.
Published: (2023-10-01)

Developments in Checkpoint Inhibitor Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer
by: Alan Su, et al.
Published: (2023-03-01)

Comprehensive Review of Immunotherapy in Colorectal Cancer: From Mechanisms to Nursing Interventions
by: Zhu Q, et al.
Published: (2026-05-01)

Impact of body composition on pathological response to neoadjuvant immunotherapy in dMMR/MSI-H colorectal cancer
by: Ziyang Zeng, et al.
Published: (2025-05-01)

Endoscopic features of deficient mismatch repair/microsatellite instability‐high and BRAF‐mutated colorectal cancer
by: Rika Omote, et al.
Published: (2026-04-01)

Traditional and New Views on MSI-H/dMMR Endometrial Cancer
by: Chuqi Liu, et al.
Published: (2025-09-01)

Double Duty: Complete Pathologic Response of Two Colonic Primaries with Mosaicism of a Novel <i>MLH1</i> Mutation to Neoadjuvant Pembrolizumab
by: Beatrice Preti, et al.
Published: (2023-10-01)

Landscape of Immunotherapy Options for Colorectal Cancer: Current Knowledge and Future Perspectives beyond Immune Checkpoint Blockade
by: Alecsandra Gorzo, et al.
Published: (2022-02-01)

Efficacy and risk analysis of monotherapy and dual immunotherapy in dMMR/MSI-H metastatic colorectal cancer: a meta-analysis based on randomized controlled trials
by: Shengqian Wang, et al.
Published: (2026-05-01)

Long-Term Survival and Clinicopathological Implications of DNA Mismatch Repair Status in Endometrioid Endometrial Cancers in Hong Kong Chinese Women
by: Jacqueline Ho Sze Lee, et al.
Published: (2021-10-01)

Survival outcomes in locally advanced dMMR rectal cancer: surgery plus adjunctive treatment vs. surgery alone
by: Kemin Ni, et al.
Published: (2023-10-01)

Iparomlimab (QL1604) in patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) unresectable or metastatic solid tumors: a pivotal, single-arm, multicenter, phase II trial
by: Feng Bi, et al.
Published: (2024-11-01)

Real-world treatment patterns and clinical outcomes for chemotherapy-based regimens in first-line MSI-H/dMMR metastatic colorectal cancer
by: Mayur M. Amonkar, et al.
Published: (2023-01-01)

The cost-effectiveness analysis of serplulimab versus regorafenib for treating previously treated unresectable or metastatic microsatellite instability-high or deficient mismatch repair colorectal cancer in China
by: Yue Ma, et al.
Published: (2023-04-01)

Concordance between immunohistochemistry and MSI analysis for detection of MMR/MSI status in colorectal cancer patients
by: Muhammad Ishaque Faizee, et al.
Published: (2024-11-01)

Incidences of colorectal adenomas and cancers under colonoscopy surveillance suggest an accelerated “Big Bang” pathway to CRC in three of the four Lynch syndromes
by: Pål Møller, et al.
Published: (2024-05-01)

Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer
by: Huijing Feng, et al.
Published: (2024-03-01)

The cost-effectiveness analysis of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair deficient advanced colorectal cancer
by: Pei Yang, et al.
Published: (2025-12-01)

Neoadjuvant PD-1 blockade with toripalimab with or without celecoxib for patients with mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): long-term outcomes of a single-centre, parallel-group, non-comparative, randomised phase 2 trialResearch in context
by: Xutao Shen, et al.
Published: (2025-10-01)

Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer
by: Yuan‐sheng Zang, et al.
Published: (2019-08-01)

Simple IHC reveals complex MMR alternations than PCR assays: Validation by LCM and next‐generation sequencing
by: Kenji Amemiya, et al.
Published: (2022-12-01)

Nationwide Real-World Data of Microsatellite Instability and/or Mismatch Repair Deficiency in Cancer: Prevalence and Testing Patterns
by: Elena Fountzilas, et al.
Published: (2024-05-01)

Patterns of germline and somatic mutations in 16 genes associated with mismatch repair function or containing tandem repeat sequences
by: Shih‐Ching Chang, et al.
Published: (2020-01-01)

CD169+ sinus macrophages in regional lymph nodes do not predict mismatch‐repair status of patients with colorectal cancer
by: Yoichi Saito, et al.
Published: (2023-05-01)

Potential predictors for CDX2 expression loss and mismatch repair deficiency in colorectal cancer
by: Ivan Vlahović, et al.
Published: (2023-05-01)

Predictive value of PD-L1 expression and dMMR/pMMR status for immune checkpoint inhibitor combined with chemotherapy in advanced/recurrent endometrial cancer: a meta-analysis
by: Lifang Lan, et al.
Published: (2026-04-01)

miR-1290 Is a Biomarker in DNA-Mismatch-Repair-Deficient Colon Cancer and Promotes Resistance to 5-Fluorouracil by Directly Targeting hMSH2
by: Ling Ye, et al.
Published: (2017-06-01)

Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer
by: Wen-Xuan Fan, et al.
Published: (2024-08-01)

Prognostic Impact of Histologic Subtypes in Mismatch Repair‐Deficient/Microsatellite Instability‐High Colorectal Cancer: A Single‐Center Retrospective Study of 1127 Stage 0–IV Patients
by: Tomoyuki Momma, et al.
Published: (2026-05-01)

Pathogenic Insights into DNA Mismatch Repair (MMR) Genes–Proteins and Microsatellite Instability: Focus on Adrenocortical Carcinoma and Beyond
by: Mara Carsote, et al.
Published: (2023-05-01)

Certain pMMR colorectal cancer patients should undergo additional MSI-PCR testing to reduce the risk of misdiagnosing MSI-H and Lynch syndrome
by: Jinglin Huang, et al.
Published: (2025-07-01)

DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphoma
by: Zijun Y. Xu-Monette, et al.
Published: (2024-12-01)

Mismatch Repair Pathway, Genome Stability and Cancer
by: Nives Pećina-Šlaus, et al.
Published: (2020-06-01)

Spontaneous regression of advanced transverse colon cancer with deficient mismatch repair: a case report
by: Shinnosuke Harata, et al.
Published: (2023-04-01)

MLH1 promoter methylation-induced dMMR/MSS in endometrial cancer: case report
by: Zhen Qu, et al.
Published: (2026-04-01)